Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 40.03-17.601.8437.9031.20

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 40.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90
Mar202031.20

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9
21.47
Mar2020 31.2 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹56,313.7 Cr -10.4% -9.5% -8.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,363.0 Cr -2.8% -3.6% 10.8% Stock Analytics
DIVIS LABORATORIES ₹158,396.0 Cr -2.5% 1.5% 59.1% Stock Analytics
CIPLA ₹117,088.0 Cr -1.5% 0.2% 1.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,458.0 Cr -1.6% -9.2% -4.3% Stock Analytics
ZYDUS LIFESCIENCES ₹94,002.4 Cr -7.4% -5.1% 9.9% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

-10.4%

-9.5%

-8.5%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses